Converge Bio Lands $25M to Replace Trial-and-Error Drug Discovery
Converge Bio Team
What You Should Know
– Converge Bio has announced a $25M Series A funding round led by Bessemer Venture Partners, bringing its total raised to $30M.
– Moving beyond the “AI promise” gap, the…
Continue Reading
